際際滷

際際滷Share a Scribd company logo
Medical management of ectopic
         pregnancy
Criteria for medical management
   No hemodynamic instability
   No tubal rupture
   Fertility desired
   Gestational sac < 3.5cm
   Beta HCG level < 5000mIu/ml
   No cardiac motion on USG
   Ability and willingness to comply with follow
    up.
Drugs commonly used are:
   Methotrexate (drug of choice)
   Potassium chloride
   Prostaglandin(PGF留)
   Hyperosmolar glucose
Methotrexate
      mechanism of action & regimens
  MOA: methotrexate depletes tetrahydrofolate cofactors for DNA & RNA synthesis
   and inhibits rapidly growing trpohoblast of EP.
 Regimens:
1)Single dose- methotrexate i.m 50mg/m族 of body surface area.
o 硫-HCG level on D and D is measured, minimum difference of > 15 percent should
   be there
o Dose to be repeated - if difference is < 15 percent b/w D and D .
    OR
o fetal cardiac activity is present on D.
o 硫-HCG level is repeated weekly until undetectable.
2)Multiple dose- methotrexate 1mg/kg i.m on D,D,D,D & lecuovorin
0 .1mg/kg i.m on D,D,D,D
o 硫-HCG level is measured every alternate day, Until decreased upto 15 percent in 2
    consecutive days
o Then weekly 硫-HCG level estimation is done until undetectable.
Contraindication of methotrexate
   Hemoperitoneum
   Breast feeding
   Immunodeficiency
   EP > 4cm
   Alcoholism
   Hepatic/Renal disease
   Blood disorder
Local injection
 20 percent potassium chloride 0.5 ml under
  USG guidance  causes asystole & resolution
  of ectopic
 Hyperosmolar glucose 1 to 3 ml injected into
  the sac.
 PGF留 when injected causes contraction and
  vasoconstriction thus resolution of pregnancy.
Oral dose
THANK YOU

More Related Content

Medical management of ectopic pregnancy

  • 1. Medical management of ectopic pregnancy
  • 2. Criteria for medical management No hemodynamic instability No tubal rupture Fertility desired Gestational sac < 3.5cm Beta HCG level < 5000mIu/ml No cardiac motion on USG Ability and willingness to comply with follow up.
  • 3. Drugs commonly used are: Methotrexate (drug of choice) Potassium chloride Prostaglandin(PGF留) Hyperosmolar glucose
  • 4. Methotrexate mechanism of action & regimens MOA: methotrexate depletes tetrahydrofolate cofactors for DNA & RNA synthesis and inhibits rapidly growing trpohoblast of EP. Regimens: 1)Single dose- methotrexate i.m 50mg/m族 of body surface area. o 硫-HCG level on D and D is measured, minimum difference of > 15 percent should be there o Dose to be repeated - if difference is < 15 percent b/w D and D . OR o fetal cardiac activity is present on D. o 硫-HCG level is repeated weekly until undetectable. 2)Multiple dose- methotrexate 1mg/kg i.m on D,D,D,D & lecuovorin 0 .1mg/kg i.m on D,D,D,D o 硫-HCG level is measured every alternate day, Until decreased upto 15 percent in 2 consecutive days o Then weekly 硫-HCG level estimation is done until undetectable.
  • 5. Contraindication of methotrexate Hemoperitoneum Breast feeding Immunodeficiency EP > 4cm Alcoholism Hepatic/Renal disease Blood disorder
  • 6. Local injection 20 percent potassium chloride 0.5 ml under USG guidance causes asystole & resolution of ectopic Hyperosmolar glucose 1 to 3 ml injected into the sac. PGF留 when injected causes contraction and vasoconstriction thus resolution of pregnancy.